Microbiota and gastrointestinal cancer

Siegel, 2018, Cancer statistics, 2018, CA Cancer J Clin, 68, 7, 10.3322/caac.21442 Hsieh, 2018, Development of a prediction model for colorectal cancer among patients with type 2 diabetes mellitus using a deep neural network, J Clin Med, 7, 10.3390/jcm7090277 Global Burden of Disease Cancer, 2017, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study, JAMA Oncology, 3, 524, 10.1001/jamaoncol.2016.5688 DoSMotIRo, 2017 Hong, 2017, The economic burden of advanced gastric cancer in Taiwan, BMC Health Serv Res, 17, 663, 10.1186/s12913-017-2609-1 Herrera, 2009, Helicobacter pylori and gastric adenocarcinoma, Clin Microbiol Infect, 15, 971, 10.1111/j.1469-0691.2009.03031.x Hsu, 2007, Helicobacter pylori infection and the risk of gastric malignancy, Am J Gastroenterol, 102, 725, 10.1111/j.1572-0241.2006.01109.x Brawner, 2014, Gastric microbiome and gastric cancer, Cancer J, 20, 211, 10.1097/PPO.0000000000000043 Collins, 2011, Microbial and viral pathogens in colorectal cancer, Lancet Oncol, 12, 504, 10.1016/S1470-2045(10)70186-8 Rajilic-Stojanovic, 2014, The first 1000 cultured species of the human gastrointestinal microbiota, FEMS Microbiol Rev, 38, 996, 10.1111/1574-6976.12075 Faith, 2013, The long-term stability of the human gut microbiota, Science, 341, 1237439, 10.1126/science.1237439 Lloyd-Price, 2016, The healthy human microbiome, Genome Med, 8, 51, 10.1186/s13073-016-0307-y Weir, 2013, Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults, PLoS One, 8, 10.1371/journal.pone.0070803 Wang, 2012, Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers, ISME J, 6, 320, 10.1038/ismej.2011.109 Wu, 2013, Dysbiosis signature of fecal microbiota in colorectal cancer patients, Microb Ecol, 66, 462, 10.1007/s00248-013-0245-9 Flemer, 2017, Tumour-associated and non-tumour-associated microbiota in colorectal cancer, Gut, 66, 633, 10.1136/gutjnl-2015-309595 Gao, 2017, Mucosa-associated microbiota signature in colorectal cancer, Eur J Clin Microbiol Infect Dis, 36, 2073, 10.1007/s10096-017-3026-4 Gao, 2015, Microbiota disbiosis is associated with colorectal cancer, Front Microbiol, 6, 20, 10.3389/fmicb.2015.00020 Yu, 2017, The gut microbiome and liver cancer: mechanisms and clinical translation, Nat Rev Gastroenterol Hepatol, 14, 527, 10.1038/nrgastro.2017.72 Schwabe, 2013, The microbiome and cancer, Nat Rev Canc, 13, 800, 10.1038/nrc3610 Jandhyala, 2015, Role of the normal gut microbiota, World J Gastroenterol, 21, 8787, 10.3748/wjg.v21.i29.8787 Blaser, 2004, Helicobacter pylori persistence: biology and disease, J Clin Invest, 113, 321, 10.1172/JCI20925 Ohnishi, 2008, Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse, Proc Natl Acad Sci, 105, 1003, 10.1073/pnas.0711183105 Bik, 2006, Molecular analysis of the bacterial microbiota in the human stomach, Proc Natl Acad Sci U S A, 103, 732, 10.1073/pnas.0506655103 Dicksved, 2009, Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls, J Med Microbiol, 58, 509, 10.1099/jmm.0.007302-0 Mowat, 2000, Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation, Gastroenterol, 119, 339, 10.1053/gast.2000.9367 Jo, 2016, Analysis of gastric microbiota by pyrosequencing: minor role of bacteria other than Helicobacter pylori in the gastric carcinogenesis, Helicobacter, 21, 364, 10.1111/hel.12293 Williams, 2005, Review article: proton pump inhibitors and bacterial overgrowth, Aliment Pharmacol Ther, 23, 3, 10.1111/j.1365-2036.2006.02707.x Wang, 2016, Bacterial overgrowth and diversification of microbiota in gastric cancer, Eur J Gastroenterol Hepatol, 28, 261, 10.1097/MEG.0000000000000542 Ferreira, 2018, Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota, Gut, 67, 226, 10.1136/gutjnl-2017-314205 Yang, 2016, Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia, Sci Rep, 6, 18594, 10.1038/srep18594 Lertpiriyapong, 2014, Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis, Gut., 63, 54, 10.1136/gutjnl-2013-305178 Aviles-Jimenez, 2014, Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer, Sci Rep, 4, 4202, 10.1038/srep04202 Eun, 2014, Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods, Helicobacter, 19, 407, 10.1111/hel.12145 Yu, 2017, Molecular characterization of the human stomach microbiota in gastric cancer patients, Front Cell Infect Microbiol, 7 Coker, 2018, Mucosal microbiome dysbiosis in gastric carcinogenesis, Gut, 67, 1024, 10.1136/gutjnl-2017-314281 Schulz, 2018, The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection, Gut., 67, 216, 10.1136/gutjnl-2016-312904 Sun, 2018, A screening method for gastric cancer by oral microbiome detection, Oncol Rep, 39, 2217 Zhang, 2015, Identification of low abundance microbiome in clinical samples using whole genome sequencing, Genome Biol, 16, 265, 10.1186/s13059-015-0821-z Andersson, 2008, Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing, PLoS One, 3, 10.1371/journal.pone.0002836 Haro, 2016, Intestinal Microbiota Is Influenced by Gender and Body Mass Index, PLoS One, 11, 10.1371/journal.pone.0154090 Ahn, 2013, Human gut microbiome and risk for colorectal cancer, JNCI J Natl Cancer Inst, 105, 1907, 10.1093/jnci/djt300 Wong, 2004, Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial, J Am Med Assoc, 291, 187, 10.1001/jama.291.2.187 Weisburger, 1975, Germ-free status and colon tumor induction by N-methyl-N'-nitro-N-nitrosoguanidine, Proc Soc Exp Biol Med, 148, 1119, 10.3181/00379727-148-38700 Rezasoltani, 2018, The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer, Microb Pathog, 124, 244, 10.1016/j.micpath.2018.08.035 Sze, 2017, Normalization of the microbiota in patients after treatment for colonic lesions, Microbiome, 5, 150, 10.1186/s40168-017-0366-3 Alozie, 2015, Streptococcus bovis infectious endocarditis and occult gastrointestinal neoplasia: experience with 25 consecutive patients treated surgically, Gut Pathog, 7, 27, 10.1186/s13099-015-0074-0 Corredoira, 2015, The clinical epidemiology and malignancies associated with Streptococcus bovis biotypes in 506 cases of bloodstream infections, J Infect, 71, 317, 10.1016/j.jinf.2015.05.005 Kajihara, 2015, Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study, BMC Infect Dis, 15, 426, 10.1186/s12879-015-1175-6 Sears, 2014, Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis, J Clin Invest, 124, 4166, 10.1172/JCI72334 Geis, 2015, Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis, Cancer Discov, 5, 1098, 10.1158/2159-8290.CD-15-0447 Viljoen, 2015, Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer, PLoS One, 10, 10.1371/journal.pone.0119462 Tilg, 2018, The intestinal microbiota in colorectal cancer, Cancer Cell, 33, 954, 10.1016/j.ccell.2018.03.004 Arthur, 2012, Intestinal inflammation targets cancer-inducing activity of the microbiota, Sci, 338, 120, 10.1126/science.1224820 Park, 2018, Intestinal microbiota, chronic inflammation, and colorectal cancer, Intest Res, 16, 338, 10.5217/ir.2018.16.3.338 Keku, 2013, Fusobacterium spp. and colorectal cancer: cause or consequence?, Trends Microbiol, 21, 506, 10.1016/j.tim.2013.08.004 Rubio, 2018, Severe Defects in the macrophage barrier to gut microflora in inflammatory bowel disease and colon cancer, Anticancer Res, 38, 3811, 10.21873/anticanres.12664 Kostic, 2013, Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment, Cell Host Microbe, 14, 207, 10.1016/j.chom.2013.07.007 Gur, 2015, Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack, Immunity, 42, 344, 10.1016/j.immuni.2015.01.010 Cani, 2018, Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer, Nat Rev Gastroenterol Hepatol, 10.1038/s41575-018-0025-6 Rossen, 2015, Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review, World J Gastroenterol, 21, 5359, 10.3748/wjg.v21.i17.5359 Filip, 2018, Fecal transplantation: digestive and extradigestive clinical applications, Clujul Med, 91, 259 Rafter, 2007, Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients, Am J Clin Nutr, 85, 488, 10.1093/ajcn/85.2.488 Mai, 2007, Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice, Mol Carcinog, 46, 42, 10.1002/mc.20233 Wiest, 2017, Targeting the gut-liver axis in liver disease, J Hepatol, 67, 1084, 10.1016/j.jhep.2017.05.007 Lin, 1995, Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation, J Hepatol, 22, 165, 10.1016/0168-8278(95)80424-2 Dapito, 2012, Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4, Cancer Cell, 21, 504, 10.1016/j.ccr.2012.02.007 Schnabl, 2014, Interactions between the intestinal microbiome and liver diseases, Gastroenterology, 146, 1513, 10.1053/j.gastro.2014.01.020 Qin, 2014, Alterations of the human gut microbiome in liver cirrhosis, Nature, 513, 59, 10.1038/nature13568 Ponziani, 2018, Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease, Hepatology Jia, 2018, Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis, Nat Rev Gastroenterol Hepatol, 15, 111, 10.1038/nrgastro.2017.119 Ma, 2018, Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells, Science, 360, 10.1126/science.aan5931 Yoshimoto, 2013, Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome, Nature, 499, 97, 10.1038/nature12347 Chen, 2011, Characterization of fecal microbial communities in patients with liver cirrhosis, Hepatology, 54, 562, 10.1002/hep.24423 Lu, 2011, Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients, Microb Ecol, 61, 693, 10.1007/s00248-010-9801-8 Xu, 2012, Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease, Microb Ecol, 63, 304, 10.1007/s00248-011-9925-5